GSE182670 ID3 ID ID1 ID4 ID2 overexpression U-87MG Uppsala RNA Messenger 1 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE182670_ID3_ID_ID1_ID4_ID2 overexpression_U-87MG Uppsala_RNA Messenger_1_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE182670_ID3_ID_ID1_ID4_ID2 overexpression_U-87MG Uppsala_RNA Messenger_1_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE182670_ID3_ID_ID1_ID4_ID2 overexpression_U-87MG Uppsala_RNA Messenger_1_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE182670_ID3_ID_ID1_ID4_ID2 overexpression_U-87MG Uppsala_RNA Messenger_1_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

MIR1915 host gene

Gene

TP53 target 1

Gene

DPPA2 upstream binding RNA

Gene

CD27 antisense RNA 1

Gene

GABPB1 intronic transcript

Gene

HERC2 pseudogene 3

Gene

MSC antisense RNA 1

Gene

ZNF503 antisense RNA 2

Gene

EDIL3 divergent transcript

Gene

GATA3 antisense RNA 1



  • Gene

    DPPA2 upstream binding RNA


  • Gene

    CD27 antisense RNA 1


  • Gene

    GABPB1 intronic transcript


  • Gene

    HERC2 pseudogene 3


  • Gene

    MSC antisense RNA 1


  • Gene

    ZNF503 antisense RNA 2


  • Gene

    EDIL3 divergent transcript


  • Gene

    GATA3 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.